Febumac 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and complications associated with elevated uric acid, such as tophi formation and joint damage. Febumac 40 is typically prescribed for patients who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. The tablet is taken orally, usually once daily, with or without food, as directed by a healthcare professional. It is important to maintain adequate hydration while on this medication to help prevent kidney stones. Febumac 40 may cause side effects including nausea, rash, liver function abnormalities, and joint pain; patients should report any unusual symptoms to their doctor promptly. Regular monitoring of liver enzymes and serum uric acid levels is recommended during treatment. Febumac 40 should be used cautiously in patients with liver or kidney impairment and is not recommended during pregnancy or breastfeeding. Always follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication.